TGFB1 and viral infectious disease: However, considering the clear contribution of TGF-β signaling to NK cell dysregulation and evidence that restraining this signaling may actually promote NK cell cytotoxicity beneficially, there warrants further investigation into the use of TGF-β inhibitors as a potential therapeutic for treating viral infections.